Alexander Christian Falkentoft

Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021

Mariam Elmegaard Malik, Alexander Christian Falkentoft, J. Steen Jensen et al. · The Lancet Regional Health - Europe · 2023 · 53 citations · Full text

Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes – a Danish nationwide observational study

Alexander Christian Falkentoft, Julie Andersen, Mariam Elmegaard Malik et al. · The Lancet Regional Health - Europe · 2022 · 51 citations · Full text

Frailty and Recurrent Hospitalization After Transcatheter Aortic Valve Replacement

Jarl Emanuel Strange, Daniel Mølager Christensen, Caroline Sindet‐Pedersen et al. · Journal of the American Heart Association · 2023 · 29 citations · Full text

Family Medicine, Heart Failure, Adult Cardiac Surgery +22

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)

Martin Schultz, Line Jee Hartmann Rasmussen, Malene Højgaard Andersen et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 2018 · 24 citations · Full text

MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

Alexander Christian Falkentoft, Rasmus Rørth, Kasper Iversen et al. · Journal of the American Heart Association · 2018 · 23 citations · Full text